#virological — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #virological, aggregated by home.social.
-
Identification of #clinical and #virological correlates associated with #influenza A candidate #vaccine virus (#CVV) attenuation in a #ferret model, https://etidiohnew.blogspot.com/2025/09/identification-of-clinical-and.html
-
Identification of #clinical and #virological correlates associated with #influenza A candidate #vaccine virus (#CVV) attenuation in a #ferret model, https://etidiohnew.blogspot.com/2025/09/identification-of-clinical-and.html
-
Identification of #clinical and #virological correlates associated with #influenza A candidate #vaccine virus (#CVV) attenuation in a #ferret model, https://etidiohnew.blogspot.com/2025/09/identification-of-clinical-and.html
-
Identification of #clinical and #virological correlates associated with #influenza A candidate #vaccine virus (#CVV) attenuation in a #ferret model, https://etidiohnew.blogspot.com/2025/09/identification-of-clinical-and.html
-
Identification of #clinical and #virological correlates associated with #influenza A candidate #vaccine virus (#CVV) attenuation in a #ferret model, https://etidiohnew.blogspot.com/2025/09/identification-of-clinical-and.html
-
#Antigenic and #virological characteristics of #SARS-CoV-2 #variants BA.3.2, #XFG, and #NB181, https://etidiohnew.blogspot.com/2025/06/antigenic-and-virological.html
-
#Antigenic and #virological characteristics of #SARS-CoV-2 #variants BA.3.2, #XFG, and #NB181, https://etidiohnew.blogspot.com/2025/06/antigenic-and-virological.html
-
#Antigenic and #virological characteristics of #SARS-CoV-2 #variants BA.3.2, #XFG, and #NB181, https://etidiohnew.blogspot.com/2025/06/antigenic-and-virological.html
-
#Antigenic and #virological characteristics of #SARS-CoV-2 #variants BA.3.2, #XFG, and #NB181, https://etidiohnew.blogspot.com/2025/06/antigenic-and-virological.html
-
#Antigenic and #virological characteristics of #SARS-CoV-2 #variants BA.3.2, #XFG, and #NB181, https://etidiohnew.blogspot.com/2025/06/antigenic-and-virological.html
-
Identification & #genetic & #virological characterisation of a #human case of avian #influenza A #H9N2 virus from Eastern #India, https://etidiohnew.blogspot.com/2025/05/identification-genetic-virological.html
-
Identification & #genetic & #virological characterisation of a #human case of avian #influenza A #H9N2 virus from Eastern #India, https://etidiohnew.blogspot.com/2025/05/identification-genetic-virological.html
-
Identification & #genetic & #virological characterisation of a #human case of avian #influenza A #H9N2 virus from Eastern #India, https://etidiohnew.blogspot.com/2025/05/identification-genetic-virological.html
-
Identification & #genetic & #virological characterisation of a #human case of avian #influenza A #H9N2 virus from Eastern #India, https://etidiohnew.blogspot.com/2025/05/identification-genetic-virological.html
-
Identification & #genetic & #virological characterisation of a #human case of avian #influenza A #H9N2 virus from Eastern #India, https://etidiohnew.blogspot.com/2025/05/identification-genetic-virological.html
-
[Correspondence] #Virological characteristics of the #SARS-CoV-2 #LP.8.1 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00079-9/fulltext?rss=yes
LP.8.1 (JN.1.11.1.1.1.3.8.1), a descendant lineage of KP.1.1.3 (JN.11.1.1.1.3), is starting to spread worldwide. LP.8.1 has acquired nine spike protein mutations compared with JN.1, and eight amino acid residues differ between the spike proteins of LP.8.1 and XEC.
-
[Correspondence] #Virological characteristics of the #SARS-CoV-2 #LP.8.1 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00079-9/fulltext?rss=yes
LP.8.1 (JN.1.11.1.1.1.3.8.1), a descendant lineage of KP.1.1.3 (JN.11.1.1.1.3), is starting to spread worldwide. LP.8.1 has acquired nine spike protein mutations compared with JN.1, and eight amino acid residues differ between the spike proteins of LP.8.1 and XEC.
-
[Correspondence] #Virological characteristics of the #SARS-CoV-2 #LP.8.1 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00079-9/fulltext?rss=yes
LP.8.1 (JN.1.11.1.1.1.3.8.1), a descendant lineage of KP.1.1.3 (JN.11.1.1.1.3), is starting to spread worldwide. LP.8.1 has acquired nine spike protein mutations compared with JN.1, and eight amino acid residues differ between the spike proteins of LP.8.1 and XEC.
-
[Correspondence] #Virological characteristics of the #SARS-CoV-2 #LP.8.1 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00079-9/fulltext?rss=yes
LP.8.1 (JN.1.11.1.1.1.3.8.1), a descendant lineage of KP.1.1.3 (JN.11.1.1.1.3), is starting to spread worldwide. LP.8.1 has acquired nine spike protein mutations compared with JN.1, and eight amino acid residues differ between the spike proteins of LP.8.1 and XEC.
-
[Correspondence] #Virological characteristics of the #SARS-CoV-2 #LP.8.1 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00079-9/fulltext?rss=yes
LP.8.1 (JN.1.11.1.1.1.3.8.1), a descendant lineage of KP.1.1.3 (JN.11.1.1.1.3), is starting to spread worldwide. LP.8.1 has acquired nine spike protein mutations compared with JN.1, and eight amino acid residues differ between the spike proteins of LP.8.1 and XEC.
-
[Correspondence] #Virological and #antigenic characteristics of #SARS-CoV-2 #variants #LF.7.2.1, #NP.1, and #LP.8.1 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00015-5/fulltext?rss=yes
... several sublineages of #JN.1 are increasingly out-competing XEC and KP.3.1.1, exhibiting superior growth advantages; for example, LF.7.2.1, MC.10.1, NP.1, and, most importantly, LP.8.1 (figure A, B).
-
[Correspondence] #Virological and #antigenic characteristics of #SARS-CoV-2 #variants #LF.7.2.1, #NP.1, and #LP.8.1 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00015-5/fulltext?rss=yes
... several sublineages of #JN.1 are increasingly out-competing XEC and KP.3.1.1, exhibiting superior growth advantages; for example, LF.7.2.1, MC.10.1, NP.1, and, most importantly, LP.8.1 (figure A, B).
-
[Correspondence] #Virological and #antigenic characteristics of #SARS-CoV-2 #variants #LF.7.2.1, #NP.1, and #LP.8.1 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00015-5/fulltext?rss=yes
... several sublineages of #JN.1 are increasingly out-competing XEC and KP.3.1.1, exhibiting superior growth advantages; for example, LF.7.2.1, MC.10.1, NP.1, and, most importantly, LP.8.1 (figure A, B).
-
[Correspondence] #Virological and #antigenic characteristics of #SARS-CoV-2 #variants #LF.7.2.1, #NP.1, and #LP.8.1 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00015-5/fulltext?rss=yes
... several sublineages of #JN.1 are increasingly out-competing XEC and KP.3.1.1, exhibiting superior growth advantages; for example, LF.7.2.1, MC.10.1, NP.1, and, most importantly, LP.8.1 (figure A, B).
-
[Correspondence] #Virological and #antigenic characteristics of #SARS-CoV-2 #variants #LF.7.2.1, #NP.1, and #LP.8.1 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00015-5/fulltext?rss=yes
... several sublineages of #JN.1 are increasingly out-competing XEC and KP.3.1.1, exhibiting superior growth advantages; for example, LF.7.2.1, MC.10.1, NP.1, and, most importantly, LP.8.1 (figure A, B).
-
#Virological characteristics of the #SARS-CoV-2 #XEC #variant
Source: Lancet Infectious Diseases, Correspondence, {Excerpt} Altogether, here we showed that XEC exhibited higher pseudovirus infectivity and higher immune evasion than KP.3. Particularly, XEC exhibited more robust immune resistance to KP.3.3 BTI sera than KP.3.1.1. Our data suggest that the higher Re of XEC than KP.3.1.1 is attributed to this property and XEC will be a predominant SARS-CoV-2 variant in the…
https://etidioh.wordpress.com/2024/11/07/virological-characteristics-of-the-sars-cov-2-xec-variant/
-
#Virological characteristics of the #SARS-CoV-2 #XEC #variant
Source: Lancet Infectious Diseases, Correspondence, {Excerpt} Altogether, here we showed that XEC exhibited higher pseudovirus infectivity and higher immune evasion than KP.3. Particularly, XEC exhibited more robust immune resistance to KP.3.3 BTI sera than KP.3.1.1. Our data suggest that the higher Re of XEC than KP.3.1.1 is attributed to this property and XEC will be a predominant SARS-CoV-2 variant in the…
https://etidioh.wordpress.com/2024/11/07/virological-characteristics-of-the-sars-cov-2-xec-variant/
-
#Virological characteristics of the #SARS-CoV-2 #XEC #variant
Source: Lancet Infectious Diseases, Correspondence, {Excerpt} Altogether, here we showed that XEC exhibited higher pseudovirus infectivity and higher immune evasion than KP.3. Particularly, XEC exhibited more robust immune resistance to KP.3.3 BTI sera than KP.3.1.1. Our data suggest that the higher Re of XEC than KP.3.1.1 is attributed to this property and XEC will be a predominant SARS-CoV-2 variant in the…
https://etidioh.wordpress.com/2024/11/07/virological-characteristics-of-the-sars-cov-2-xec-variant/
-
#Virological characteristics of the #SARS-CoV-2 #XEC #variant
Source: Lancet Infectious Diseases, Correspondence, {Excerpt} Altogether, here we showed that XEC exhibited higher pseudovirus infectivity and higher immune evasion than KP.3. Particularly, XEC exhibited more robust immune resistance to KP.3.3 BTI sera than KP.3.1.1. Our data suggest that the higher Re of XEC than KP.3.1.1 is attributed to this property and XEC will be a predominant SARS-CoV-2 variant in the…
https://etidioh.wordpress.com/2024/11/07/virological-characteristics-of-the-sars-cov-2-xec-variant/
-
#Virological characteristics of the #SARS-CoV-2 #XEC #variant
Source: Lancet Infectious Diseases, Correspondence, {Excerpt} Altogether, here we showed that XEC exhibited higher pseudovirus infectivity and higher immune evasion than KP.3. Particularly, XEC exhibited more robust immune resistance to KP.3.3 BTI sera than KP.3.1.1. Our data suggest that the higher Re of XEC than KP.3.1.1 is attributed to this property and XEC will be a predominant SARS-CoV-2 variant in the…
https://etidioh.wordpress.com/2024/11/07/virological-characteristics-of-the-sars-cov-2-xec-variant/
-
#Virological #characteristics of the #SARS-CoV-2 #KP311 #variant http://biorxiv.org/cgi/content/short/2024.07.16.603835v1?rss=1
KP.3.1.1 exhibited a higher Re, higher pseudovirus infectivity, & higher neutralization #evasion than KP.3. These results align with our recent report that #JN1 subvariants with S:S31del (eg KP.2.3 & LB.1) exhibited enhanced Re and immune evasion compared to other JN.1 subvariants without S:S31del (eg JN.1, KP.2, & KP.3), highlighting evolutionary significance of S:S31del in JN.1 lineages.
-
#Virological #characteristics of the #SARS-CoV-2 #KP311 #variant http://biorxiv.org/cgi/content/short/2024.07.16.603835v1?rss=1
KP.3.1.1 exhibited a higher Re, higher pseudovirus infectivity, & higher neutralization #evasion than KP.3. These results align with our recent report that #JN1 subvariants with S:S31del (eg KP.2.3 & LB.1) exhibited enhanced Re and immune evasion compared to other JN.1 subvariants without S:S31del (eg JN.1, KP.2, & KP.3), highlighting evolutionary significance of S:S31del in JN.1 lineages.
-
#Virological #characteristics of the #SARS-CoV-2 #KP311 #variant http://biorxiv.org/cgi/content/short/2024.07.16.603835v1?rss=1
KP.3.1.1 exhibited a higher Re, higher pseudovirus infectivity, & higher neutralization #evasion than KP.3. These results align with our recent report that #JN1 subvariants with S:S31del (eg KP.2.3 & LB.1) exhibited enhanced Re and immune evasion compared to other JN.1 subvariants without S:S31del (eg JN.1, KP.2, & KP.3), highlighting evolutionary significance of S:S31del in JN.1 lineages.
-
#Virological #characteristics of the #SARS-CoV-2 #KP311 #variant http://biorxiv.org/cgi/content/short/2024.07.16.603835v1?rss=1
KP.3.1.1 exhibited a higher Re, higher pseudovirus infectivity, & higher neutralization #evasion than KP.3. These results align with our recent report that #JN1 subvariants with S:S31del (eg KP.2.3 & LB.1) exhibited enhanced Re and immune evasion compared to other JN.1 subvariants without S:S31del (eg JN.1, KP.2, & KP.3), highlighting evolutionary significance of S:S31del in JN.1 lineages.
-
#Virological #characteristics of the #SARS-CoV-2 #KP311 #variant http://biorxiv.org/cgi/content/short/2024.07.16.603835v1?rss=1
KP.3.1.1 exhibited a higher Re, higher pseudovirus infectivity, & higher neutralization #evasion than KP.3. These results align with our recent report that #JN1 subvariants with S:S31del (eg KP.2.3 & LB.1) exhibited enhanced Re and immune evasion compared to other JN.1 subvariants without S:S31del (eg JN.1, KP.2, & KP.3), highlighting evolutionary significance of S:S31del in JN.1 lineages.
-
#Virological characteristics of the #SARS-CoV-2 #KP3, #LB1, and #KP23 #variants, Lancet Infect Dis.: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00415-8/fulltext?rss=yes
JN.1 subvariants such as LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2·3), which convergently acquired a deletion at the 31st position in S (Ser31del) in addition to the aforementioned substitutions, have emerged and spread as of June, 2024 (appendix pp 12–13).
-
#Virological characteristics of the #SARS-CoV-2 #KP3, #LB1, and #KP23 #variants, Lancet Infect Dis.: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00415-8/fulltext?rss=yes
JN.1 subvariants such as LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2·3), which convergently acquired a deletion at the 31st position in S (Ser31del) in addition to the aforementioned substitutions, have emerged and spread as of June, 2024 (appendix pp 12–13).
-
#Virological characteristics of the #SARS-CoV-2 #KP3, #LB1, and #KP23 #variants, Lancet Infect Dis.: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00415-8/fulltext?rss=yes
JN.1 subvariants such as LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2·3), which convergently acquired a deletion at the 31st position in S (Ser31del) in addition to the aforementioned substitutions, have emerged and spread as of June, 2024 (appendix pp 12–13).
-
#Virological characteristics of the #SARS-CoV-2 #KP3, #LB1, and #KP23 #variants, Lancet Infect Dis.: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00415-8/fulltext?rss=yes
JN.1 subvariants such as LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2·3), which convergently acquired a deletion at the 31st position in S (Ser31del) in addition to the aforementioned substitutions, have emerged and spread as of June, 2024 (appendix pp 12–13).
-
#Virological characteristics of the #SARS-CoV-2 #KP3, #LB1, and #KP23 #variants, Lancet Infect Dis.: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00415-8/fulltext?rss=yes
JN.1 subvariants such as LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2·3), which convergently acquired a deletion at the 31st position in S (Ser31del) in addition to the aforementioned substitutions, have emerged and spread as of June, 2024 (appendix pp 12–13).
-
#Virological characteristics of the #SarsCoV2 #KP3, #LB1 and #KP23 #variants, BioRxIV, https://www.biorxiv.org/content/10.1101/2024.06.05.597664v1?rss=1
Our results suggest that S #substitutions convergently acquired in #JN1 #subvariants contribute to immune evasion, & increase their Re when compared to parental JN.1. LB.1 & KP.2.3 exhibited higher pseudovirus #infectivity & more immune resistance than KP.2. Data suggest that S:S31del is critical to exhibit +infectivity, +immune evasion, & potentially contributes to increased Re.
-
#Virological characteristics of the #SarsCoV2 #KP3, #LB1 and #KP23 #variants, BioRxIV, https://www.biorxiv.org/content/10.1101/2024.06.05.597664v1?rss=1
Our results suggest that S #substitutions convergently acquired in #JN1 #subvariants contribute to immune evasion, & increase their Re when compared to parental JN.1. LB.1 & KP.2.3 exhibited higher pseudovirus #infectivity & more immune resistance than KP.2. Data suggest that S:S31del is critical to exhibit +infectivity, +immune evasion, & potentially contributes to increased Re.
-
#Virological characteristics of the #SarsCoV2 #KP3, #LB1 and #KP23 #variants, BioRxIV, https://www.biorxiv.org/content/10.1101/2024.06.05.597664v1?rss=1
Our results suggest that S #substitutions convergently acquired in #JN1 #subvariants contribute to immune evasion, & increase their Re when compared to parental JN.1. LB.1 & KP.2.3 exhibited higher pseudovirus #infectivity & more immune resistance than KP.2. Data suggest that S:S31del is critical to exhibit +infectivity, +immune evasion, & potentially contributes to increased Re.
-
#Virological characteristics of the #SarsCoV2 #KP3, #LB1 and #KP23 #variants, BioRxIV, https://www.biorxiv.org/content/10.1101/2024.06.05.597664v1?rss=1
Our results suggest that S #substitutions convergently acquired in #JN1 #subvariants contribute to immune evasion, & increase their Re when compared to parental JN.1. LB.1 & KP.2.3 exhibited higher pseudovirus #infectivity & more immune resistance than KP.2. Data suggest that S:S31del is critical to exhibit +infectivity, +immune evasion, & potentially contributes to increased Re.
-
#Virological characteristics of the #SarsCoV2 #KP3, #LB1 and #KP23 #variants, BioRxIV, https://www.biorxiv.org/content/10.1101/2024.06.05.597664v1?rss=1
Our results suggest that S #substitutions convergently acquired in #JN1 #subvariants contribute to immune evasion, & increase their Re when compared to parental JN.1. LB.1 & KP.2.3 exhibited higher pseudovirus #infectivity & more immune resistance than KP.2. Data suggest that S:S31del is critical to exhibit +infectivity, +immune evasion, & potentially contributes to increased Re.
-
[Correspondence] #Virological characteristics of the #SarsCoV2 #KP2 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00298-6/fulltext?rss=yes
Particularly, the KP.2 (JN.1.11.1.2) variant, a descendant of JN.1 bearing both S:R346T and S:F456L, is rapidly spreading in multiple regions as of April, 2024. Here, we investigated the virological properties of KP.2.
-
[Correspondence] #Virological characteristics of the #SarsCoV2 #KP2 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00298-6/fulltext?rss=yes
Particularly, the KP.2 (JN.1.11.1.2) variant, a descendant of JN.1 bearing both S:R346T and S:F456L, is rapidly spreading in multiple regions as of April, 2024. Here, we investigated the virological properties of KP.2.
-
[Correspondence] #Virological characteristics of the #SarsCoV2 #KP2 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00298-6/fulltext?rss=yes
Particularly, the KP.2 (JN.1.11.1.2) variant, a descendant of JN.1 bearing both S:R346T and S:F456L, is rapidly spreading in multiple regions as of April, 2024. Here, we investigated the virological properties of KP.2.
-
[Correspondence] #Virological characteristics of the #SarsCoV2 #KP2 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00298-6/fulltext?rss=yes
Particularly, the KP.2 (JN.1.11.1.2) variant, a descendant of JN.1 bearing both S:R346T and S:F456L, is rapidly spreading in multiple regions as of April, 2024. Here, we investigated the virological properties of KP.2.
-
[Correspondence] #Virological characteristics of the #SarsCoV2 #KP2 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00298-6/fulltext?rss=yes
Particularly, the KP.2 (JN.1.11.1.2) variant, a descendant of JN.1 bearing both S:R346T and S:F456L, is rapidly spreading in multiple regions as of April, 2024. Here, we investigated the virological properties of KP.2.